InvestorsHub Logo
Followers 19
Posts 3820
Boards Moderated 0
Alias Born 09/23/2014

Re: longtermgems post# 34494

Monday, 03/21/2016 4:49:27 PM

Monday, March 21, 2016 4:49:27 PM

Post# of 140477
At least they gave a damn about the product and have gotten us a next generation surgical robotics platform. Whereas TRXC didn't care about the shareholders ($14/share at one point) or the product (surgibot reviews are very poor and ALF-X hasn't been sold since approval 4 years ago).

Will say this, not too pleased with EVC telling some shareholders that financing wasn't imminent and then having an overnight. That is something I expected out of the other IR firm we had.